Drug Induced Muscle Disorders

A note on drug induced musculoskeletal disorders that can potentially affect the spectrum of anatomical structures including bone, connective tissue and the musculature is provided. Myalgia, Myositis, Rhabdomyolysis are some of the forms of such disorder and common myotoxic drugs and their presentation are provided.

[1]  T. Gillessen,et al.  Iatrogenic and toxic myopathies , 2003, Muscle & nerve.

[2]  R. Seidman,et al.  Drug-Induced Myopathy and Neuropathy , 2003, Journal of clinical neuromuscular disease.

[3]  A. Chugh,et al.  Statins and myotoxicity: a therapeutic limitation , 2006, Expert opinion on drug safety.

[4]  A. Tonkin,et al.  National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005. , 2005 .

[5]  J. Stein,et al.  Outcomes in 45 patients with statin-associated myopathy. , 2005, Archives of internal medicine.

[6]  A. Husband.  Managing statin-induced myopathy. , 2009 .

[7]  R. Alonso,et al.  Benefits and risks assessment of simvastatin in familial hypercholesterolaemia , 2005, Expert opinion on drug safety.

[8]  S. Lines,et al.  Dipstick test for myoglobinuria , 2008, BMJ : British Medical Journal.

[9]  R. Wortmann.  Lipid-lowering agents and myopathy , 2002, Current opinion in rheumatology.

[10]  Penny Franklin,et al.  Adverse Drug Reactions, 2nd edn , 2007 .

[11]  I. Boyd,et al.  Risk Factors for Rhabdomyolysis with Simvastatin and Atorvastatin , 2006, Drug safety.

[12]  J. Hallas,et al.  Lipid-Lowering Drugs and Risk of Myopathy: A Population-Based Follow-Up Study , 2001, Epidemiology.

[13]  Zachary Simmons,et al.  Genetic risk factors associated with lipid‐lowering drug‐induced myopathies , 2006, Muscle & nerve.

[14]  R. Rosenson.  Current overview of statin-induced myopathy. , 2004, The American journal of medicine.

[15]  S. R. Fine,et al.  ADVERSE DRUG REACTIONS , 2009, BMJ : British Medical Journal.

[16]  H. Chiu,et al.  Colchicine-induced acute myopathy in a patient with concomitant use of simvastatin. , 2002, Clinical neuropharmacology.

[17]  M. Davidson,et al.  Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. , 2005, The American journal of cardiology.